ESLATAM

pharmaceutical preparations and substances, namely, analgesics; anti-infectives; anti-inflammatories; pharmaceutical products and preparations, namely, products for the treatment of epilepsy, neuropathic pain, and bipolar disorder; anti-epileptic drugs; pharmaceutical products, preparations and substances for the prevention and treatment of disorders and diseases of the central nervous system, peripheral nervous system, respiratory system, urogenital system, cardiovascular system, endocrine system, metabolic system, renal system, gastroenterologic system, ophthalmologic system, and dermatologic system; pharmaceutical preparations and substances for the prevention and treatment of hematologic and oncologic disorders and diseases, psychiatric disorders and diseases, allergic disorders and diseases and disorders and diseases of the immune system, connective tissue and joints; pharmaceutical preparations and substances for the prevention and treatment of insomnia and other sleep related diseases and disorders; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations and substances for the prevention and treatment of attention deficit disorder and attention deficit hyperactivity disorder; pharmaceutical preparations and substances for the prevention and treatment of eating disorders; pharmaceutical preparations for use in respiratory therapy and for the treatment of lung, nasal and other respiratory system conditions and disorders, chronic obstructive pulmonary disease, asthma and allergies